US Patent 7973136 Optimized anti-CD30 antibodies
Patent 7973136 was granted and assigned to Xencor on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+312 characters)
Article
Patent abstract
An antibody that targets CD30, wherein the antibody comprises at least one modification relative to a parent antibody and the antibody binds with altered affinity to an FcgR or alters effector function as compared to the parent antibody. Also disclosed are methods of using the anti-CD30 antibody.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Bao-lu Chen0
David F. Carmichael0
Gregory Alan Lazar0
John R. Desjarlais0
Lori Kunkel0
Philip W. Hammond0
Seung Y. Chu0
Sher Bahadur Karki0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07973136 Optimized anti-CD30 antibodies US Patent 7973136 Optimized anti-CD30 antibodies
Infobox
Patent Number
079731360
Patent Number
79731360
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079731360
Date of Patent
July 5, 2011
0Patent Application Number
120893840
Date Filed
October 6, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07973136 Optimized anti-CD30 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07973136
Date of patent
July 5, 2011
Patent application number
12089384
Date Filed
October 6, 2006
Patent primary examiner
Find more entities like US Patent 7973136 Optimized anti-CD30 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
